New Zealand markets close in 1 hour 25 minutes
  • NZX 50

    12,050.93
    +27.47 (+0.23%)
     
  • NZD/USD

    0.6512
    +0.0019 (+0.29%)
     
  • NZD/EUR

    0.5977
    +0.0022 (+0.38%)
     
  • ALL ORDS

    7,725.60
    +37.60 (+0.49%)
     
  • ASX 200

    7,507.50
    +39.20 (+0.52%)
     
  • OIL

    81.22
    +0.21 (+0.26%)
     
  • GOLD

    1,928.10
    -1.90 (-0.10%)
     
  • NASDAQ

    12,051.48
    +236.79 (+2.00%)
     
  • FTSE

    7,761.11
    +16.24 (+0.21%)
     
  • Dow Jones

    33,949.41
    +205.57 (+0.61%)
     
  • DAX

    15,132.85
    +51.21 (+0.34%)
     
  • Hang Seng

    22,633.04
    +66.26 (+0.29%)
     
  • NIKKEI 225

    27,384.07
    +21.32 (+0.08%)
     
  • NZD/JPY

    84.3940
    -0.0200 (-0.02%)
     

Investors one-year losses continue as Akzo Nobel (AMS:AKZA) dips a further 3.5% this week, earnings continue to decline

The simplest way to benefit from a rising market is to buy an index fund. When you buy individual stocks, you can make higher profits, but you also face the risk of under-performance. Investors in Akzo Nobel N.V. (AMS:AKZA) have tasted that bitter downside in the last year, as the share price dropped 32%. That falls noticeably short of the market decline of around 12%. Even if shareholders bought some time ago, they wouldn't be particularly happy: the stock is down 26% in three years.

Given the past week has been tough on shareholders, let's investigate the fundamentals and see what we can learn.

View our latest analysis for Akzo Nobel

While the efficient markets hypothesis continues to be taught by some, it has been proven that markets are over-reactive dynamic systems, and investors are not always rational. One imperfect but simple way to consider how the market perception of a company has shifted is to compare the change in the earnings per share (EPS) with the share price movement.

Unfortunately Akzo Nobel reported an EPS drop of 29% for the last year. We note that the 32% share price drop is very close to the EPS drop. Given the lower EPS we might have expected investors to lose confidence in the stock, but that doesn't seemed to have happened. Instead, the change in the share price seems to reduction in earnings per share, alone.

You can see how EPS has changed over time in the image below (click on the chart to see the exact values).

earnings-per-share-growth
earnings-per-share-growth

We consider it positive that insiders have made significant purchases in the last year. Even so, future earnings will be far more important to whether current shareholders make money. This free interactive report on Akzo Nobel's earnings, revenue and cash flow is a great place to start, if you want to investigate the stock further.

A Different Perspective

While the broader market lost about 12% in the twelve months, Akzo Nobel shareholders did even worse, losing 30% (even including dividends). However, it could simply be that the share price has been impacted by broader market jitters. It might be worth keeping an eye on the fundamentals, in case there's a good opportunity. Longer term investors wouldn't be so upset, since they would have made 1.2%, each year, over five years. It could be that the recent sell-off is an opportunity, so it may be worth checking the fundamental data for signs of a long term growth trend. While it is well worth considering the different impacts that market conditions can have on the share price, there are other factors that are even more important. For example, we've discovered 3 warning signs for Akzo Nobel (1 is a bit unpleasant!) that you should be aware of before investing here.

Akzo Nobel is not the only stock insiders are buying. So take a peek at this free list of growing companies with insider buying.

Please note, the market returns quoted in this article reflect the market weighted average returns of stocks that currently trade on NL exchanges.

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

Join A Paid User Research Session
You’ll receive a US$30 Amazon Gift card for 1 hour of your time while helping us build better investing tools for the individual investors like yourself. Sign up here